Warning: The NCBI web site requires JavaScript to function. more...
Use of metabolic markers to identify overweight individuals who are insulin resistant.
McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, Reaven G.
Ann Intern Med. 2003 Nov 18;139(10):802-9.PMID: 14623617 [PubMed - indexed for MEDLINE]Related articlesFree article
Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease?
McLaughlin T, Reaven G, Abbasi F, Lamendola C, Saad M, Waters D, Simon J, Krauss RM.
Am J Cardiol. 2005 Aug 1;96(3):399-404.PMID: 16054467 [PubMed - indexed for MEDLINE]Related articles
Prevalence of insulin resistance and associated cardiovascular disease risk factors among normal weight, overweight, and obese individuals.
McLaughlin T, Allison G, Abbasi F, Lamendola C, Reaven G.
Metabolism. 2004 Apr;53(4):495-9.PMID: 15045698 [PubMed - indexed for MEDLINE]Related articles
Metabolic syndrome in nondiabetic, obese, first-degree relatives of African American patients with type 2 diabetes: African American triglycerides-HDL-C and insulin resistance paradox.
Meis SB, Schuster D, Gaillard T, Osei K.
Ethn Dis. 2006 Autumn;16(4):830-6.PMID: 17061734 [PubMed - indexed for MEDLINE]Related articles
Components of the metabolic syndrome among a sample of overweight and obese Costa Rican schoolchildren.
Holst-Schumacher I, Nuñez-Rivas H, Monge-Rojas R, Barrantes-Santamaría M.
Food Nutr Bull. 2009 Jun;30(2):161-70.PMID: 19689095 [PubMed - indexed for MEDLINE]Related articles
Fasting triglyceride and the triglyceride-HDL cholesterol ratio are not markers of insulin resistance in African Americans.
Sumner AE, Finley KB, Genovese DJ, Criqui MH, Boston RC.
Arch Intern Med. 2005 Jun 27;165(12):1395-400.PMID: 15983289 [PubMed - indexed for MEDLINE]Related articlesFree article
Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes mellitus in obese individuals: effect of differences in insulin sensitivity.
McLaughlin T, Abbasi F, Lamendola C, Reaven G.
Arch Intern Med. 2007 Apr 9;167(7):642-8.PMID: 17420421 [PubMed - indexed for MEDLINE]Related articlesFree article
Serum insulin and inflammatory markers in overweight individuals with and without dyslipidemia.
Barter P, McPherson YR, Song K, Kesäniemi YA, Mahley R, Waeber G, Bersot T, Mooser V, Waterworth D, Grundy SM.
J Clin Endocrinol Metab. 2007 Jun;92(6):2041-5. Epub 2007 Mar 27.PMID: 17389699 [PubMed - indexed for MEDLINE]Related articlesFree article
Use of markers of dyslipidemia to identify overweight youth with insulin resistance.
Hannon TS, Bacha F, Lee SJ, Janosky J, Arslanian SA.
Pediatr Diabetes. 2006 Oct;7(5):260-6.PMID: 17054447 [PubMed - indexed for MEDLINE]Related articles
Obesity, insulin resistance, and cardiovascular disease.
Reaven G, Abbasi F, McLaughlin T.
Recent Prog Horm Res. 2004;59:207-23. Review.PMID: 14749503 [PubMed - indexed for MEDLINE]Related articlesFree article
Comparison of body mass index versus waist circumference with the metabolic changes that increase the risk of cardiovascular disease in insulin-resistant individuals.
Farin HM, Abbasi F, Reaven GM.
Am J Cardiol. 2006 Oct 15;98(8):1053-6. Epub 2006 Aug 28.PMID: 17027570 [PubMed - indexed for MEDLINE]Related articles
Coronary heart disease risk factor profiles in black patients with non-insulin-dependent diabetes mellitus: paradoxic patterns.
Banerji MA, Lebovitz HE.
Am J Med. 1991 Jul;91(1):51-8.PMID: 1858830 [PubMed - indexed for MEDLINE]Related articles
Effect of body mass index on insulin resistance and lipids in prepubertal and postpubertal children: SCHOOL observations.
Murdock DK, Olson KJ, Juza RM, Hendricks BL.
J Cardiometab Syndr. 2006 Summer;1(4):242-7.PMID: 17679804 [PubMed - indexed for MEDLINE]Related articles
Relationship to insulin resistance of the adult treatment panel III diagnostic criteria for identification of the metabolic syndrome.
Cheal KL, Abbasi F, Lamendola C, McLaughlin T, Reaven GM, Ford ES.
Diabetes. 2004 May;53(5):1195-200.PMID: 15111486 [PubMed - indexed for MEDLINE]Related articlesFree article
Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes.
Mojiminiyi OA, Abdella NA, Al Arouj M, Ben Nakhi A.
Int J Obes (Lond). 2007 Feb;31(2):213-20. Epub 2006 Jun 6.PMID: 16755284 [PubMed - indexed for MEDLINE]Related articles
Weight loss improves heart rate recovery in overweight and obese men with features of the metabolic syndrome.
Brinkworth GD, Noakes M, Buckley JD, Clifton PM.
Am Heart J. 2006 Oct;152(4):693.e1-6.PMID: 16996838 [PubMed - indexed for MEDLINE]Related articles
Critical evaluation of adult treatment panel III criteria in identifying insulin resistance with dyslipidemia.
Liao Y, Kwon S, Shaughnessy S, Wallace P, Hutto A, Jenkins AJ, Klein RL, Garvey WT.
Diabetes Care. 2004 Apr;27(4):978-83.PMID: 15047659 [PubMed - indexed for MEDLINE]Related articlesFree article
Relationship between changes in insulin sensitivity and associated cardiovascular disease risk factors in thiazolidinedione-treated, insulin-resistant, nondiabetic individuals: pioglitazone versus rosiglitazone.
Abbasi F, Lima NK, Reaven GM.
Metabolism. 2009 Mar;58(3):373-8.PMID: 19217454 [PubMed - indexed for MEDLINE]Related articles
Ethnic differences in the ability of triglyceride levels to identify insulin resistance.
Sumner AE, Cowie CC.
Atherosclerosis. 2008 Feb;196(2):696-703. Epub 2007 Jan 24.PMID: 17254586 [PubMed - indexed for MEDLINE]Related articles
Summaries for patients. Use of common laboratory tests to identify people with insulin resistance.
[No authors listed]
Ann Intern Med. 2003 Nov 18;139(10):I16. No abstract available. PMID: 14623638 [PubMed - indexed for MEDLINE]Related articlesFree article
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on
» See more...